Step 1 topics → Microbiology → Streptococcus pyogenes (Group A Strep)

Streptococcus pyogenes (Group A Strep)

USMLE Step 1 trap: Confuses rheumatic fever pathogenesis with direct GAS cardiac invasion rather than molecular mimicry. Rheumatic fever results from molecular mimicry: antibodies against GAS M protein cross-react with cardiac antigens (myosin, valve glycoproteins), causing autoimmune carditis without direct bacterial invasion.

Streptococcus pyogenes (Group A Strep, GAS) is one of the highest-yield bacteria on USMLE Step 1, and it carries a prevention asymmetry the exam loves to test: antibiotics given for GAS pharyngitis reliably prevent rheumatic fever, but they do NOT prevent post-streptococcal glomerulonephritis — PSGN can follow either throat or skin infections regardless of antibiotic treatment. The exam hits GAS from three angles: lab-based identification (gram-positive cocci in chains, beta-hemolytic, bacitracin-sensitive), suppurative disease (pharyngitis, necrotizing fasciitis, toxic shock), and post-infectious complications (rheumatic fever, PSGN). A single vignette might give you a throat culture result and then ask what complication you can or cannot prevent with antibiotics — you need that distinction locked in.

The tricky part is that GAS has a large footprint — strep throat, scarlet fever, impetigo, cellulitis, necrotizing fasciitis, toxic shock, rheumatic fever, and PSGN all trace back to the same organism, but through completely different mechanisms. Students who memorize the disease list without understanding pathogenesis get caught when the exam asks *why* rheumatic fever causes valve damage or *why* antibiotics help in one scenario but not another. The nonsuppurative complications (rheumatic fever, PSGN) are particularly dangerous because students often conflate them, applying the same rules to both when the rules are actually different.

On USMLE Step 1, GAS identification questions almost always come down to a few key features: gram-positive cocci in chains, beta-hemolysis on blood agar, bacitracin sensitivity, and Lancefield Group A antigen (detected by the rapid strep test). The lab discriminator most students miss is the bacitracin disk — it separates GAS from Group B Strep, not from all strep. If you don't have that distinction locked in, one distractor will catch you every time.

From real student decks
86%have cards covering this topic
78%have mature cards
1.0median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Rheumatic fever is caused by direct invasion of cardiac tissue by GAS.
Right: Rheumatic fever results from molecular mimicry: antibodies against GAS M protein cross-react with cardiac antigens (myosin, valve glycoproteins), causing autoimmune carditis without direct bacterial invasion.
Rheumatic fever is not an infection of the heart — GAS does not actually invade cardiac tissue. Instead, the immune system generates antibodies against the GAS M protein, and those antibodies cross-react with structurally similar cardiac proteins (especially myosin and valve glycoproteins) through molecular mimicry. The resulting autoimmune inflammation damages the endocardium and valves even though no bacteria are present there. This is why cultures are negative in active rheumatic carditis and why the damage is immune-mediated, not infectious.
Common mistake
Wrong: Treating GAS pharyngitis with antibiotics prevents post-streptococcal glomerulonephritis.
Right: Antibiotic treatment of GAS pharyngitis prevents rheumatic fever but does NOT prevent post-streptococcal glomerulonephritis, which can follow either throat or skin infections.
Antibiotics given for GAS pharyngitis reliably prevent rheumatic fever — this is why you treat strep throat even in mild cases. But PSGN is a different story: antibiotic treatment does NOT prevent post-streptococcal glomerulonephritis, and PSGN can follow either throat OR skin GAS infections. The two complications share the same causative organism but have different pathogenic mechanisms and different responses to intervention, so you can't apply the same prevention logic to both.
Common mistake
Wrong: Bacitracin sensitivity is a feature shared by all beta-hemolytic streptococci.
Right: Bacitracin sensitivity is specific to Group A Strep (S. pyogenes); Group B Strep (S. agalactiae) is bacitracin resistant, making the disk test a key differentiator.
Bacitracin sensitivity is NOT a property of all beta-hemolytic streptococci — it specifically identifies Group A Strep. Group B Strep (S. agalactiae) is bacitracin resistant, which is exactly why the bacitracin disk test exists: to differentiate GAS from GBS on a blood agar plate showing beta-hemolysis. If you see a beta-hemolytic strep that is bacitracin resistant, think Group B, not Group A. Getting this backward will cost you points on any identification question that uses the disk test as the discriminating feature.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify GAS in lab vignettes using gram stain morphology, hemolysis pattern, bacitracin sensitivity, and serologic grouping — and distinguish it from other beta-hemolytic streptococci like Group B Strep.
  2. Recognize the full spectrum of suppurative GAS infections — pharyngitis, impetigo, erysipelas, cellulitis, necrotizing fasciitis, and streptococcal toxic shock syndrome — and match clinical features to the correct syndrome.
  3. Explain the post-infectious immune complications of GAS (rheumatic fever and PSGN), their distinct pathogenic mechanisms, and which one can be prevented by antibiotic treatment.

Can you avoid these mistakes?

A throat culture grows gram-positive cocci in chains with beta-hemolysis. A bacitracin disk is placed and shows a zone of inhibition. What is the organism, and what two nonsuppurative complications does this organism cause weeks after infection?
A 10-year-old develops hematuria, hypertension, and periorbital edema 3 weeks after a skin infection. His physician says antibiotics wouldn't have prevented this. What is the diagnosis, what caused the original skin infection, and why didn't antibiotics help?
You're comparing two beta-hemolytic strep isolates: one is sensitive to bacitracin, the other is resistant. What Lancefield groups do these correspond to, and what clinical scenario is each most associated with?
A cardiology fellow says rheumatic fever damages heart valves because GAS directly infects the endocardium. What is wrong with this explanation, and what is the correct mechanism? Name the specific bacterial antigen and the cardiac protein involved.

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →